Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients

Development and Validation of an Individualized Metabolism-Related Prognostic Model for Adult Acute Myeloid Leukemia Patients

ObjectivesAcute myeloid leukemia (AML) is a highly heterogeneous hematologic malignancy with widely variable prognosis. For this reason, a more tailored-stratified approach for prognosis is urgently needed to improve the treatment success rates of AML patients.MethodsIn the investigation of metaboli...

Full description

Bibliographic Details
Main Authors: Cong Wei, Lijuan Ding, Qian Luo, Xiaoqing Li, Xiangjun Zeng, Delin Kong, Xiaohong Yu, Jingjing Feng, Yishan Ye, Limengmeng Wang, He Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukemia
MRPSI
MCPMI
prognosis
drug response
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.829007/full

Similar Items

Similar Items